On Invalid Date, Jaguar Health (NASDAQ: JAGX) reported Q2 2023 earnings per share (EPS) of -$0.69, up 92.13% year over year. Total Jaguar Health earnings for the quarter were -$12.15 million. In the same quarter last year, Jaguar Health's earnings per share (EPS) was -$8.77.
On Invalid Date, Jaguar Health (NASDAQ: JAGX) reported Q2 2023 revenue of $2.68 million up 8.39% year over year. In the same quarter last year, Jaguar Health's revenue was $2.92 million.
What was JAGX's revenue growth in the past year?
As of Q3 2023, Jaguar Health's revenue has grown 33.94% year over year. This is 66.8 percentage points lower than the US Biotechnology industry revenue growth rate of 100.74%. Jaguar Health's revenue in the past year totalled $11.06 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.